Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options

Michael Carter

Approximately 85% of people switched to protease inhibitor-based second-line antiretroviral (ART) in sub-Saharan Africa achieve and maintain an undetectable viral load with their new regimen, according to research in the online edition of Clinical Infectious Diseases.

Non-standard first-line treatment, poor adherence and previous resistance to protease inhibitors were also associated with the virological failure of second-line treatment. Genotypic resistance testing on people with a viral load above 1000 copies/ml showed that a fifth had major resistance to drugs in the protease inhibitor class and that resistance to nucleoside reverse transcriptase inhibitors (NRTIs) was widespread.

However, while this study found that future treatment of individuals with failure of second-line ART requires third-line drug options, these are currently unavailable and/or unaffordable in the public sector in sub-Saharan Africa.

August 22, 2016
Year of publication
2016
Resource types
Journal and research articles
Tags
second-line ART, undetectable viral load, first-line ART, adherence, drug resistance, virological failure, third-line ART, treatment options

Similar Resources

Fungi are major contributors to the opportunistic infections that affect patients with HIV/AIDS.

Adolescents newly diagnosed with HIV need to be rapidly incorporated into HIV care networks to have the best chances of remaining in care in the long term, research from the United States published in the June 1st edition of the Journal of Acquired Immune Deficiency Syndromes shows.

BACKGROUND:

Attrition along the HIV care continuum slows gains in mitigating the South African HIV epidemic. Understanding population-level gaps in HIV identification, linkage, retention in care and viral suppression is critical to target programming.

There is significant attrition at each stage of the HIV care continuum in South Africa, according to a study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The population-based research was conducted in North West Province and revealed that of…

Advances in biomedical technologies provide potential for adolescent HIV prevention and HIV-positive survival.

High adherence to antiretroviral therapy is crucial to the success of HIV treatment. We evaluated comparative effectiveness of adherence interventions with the aim of informing the WHO's global guidance on interventions to increase adherence.

Despite more than two decades of research on adherence to antiretroviral therapy (ART) and more than 17 million HIV-positive individuals on treatment, adherence to ART remains a major challenge. This review aimed to assess the most frequently reported barriers to adherence by patients…

Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resistant or rifampicin-resistant (MDR/RR), which is often interpreted as evidence that drug resistance results mainly from poor treatment adherence.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.